Dewpoint Therapeutics raises $77 million to go after ‘undruggable’ diseases

September 29th, 2020 | Boston Globe

Dewpoint Therapeutics announced Tuesday that it has raised $77 million in its second round of venture funding, which will help the company continue to target “undruggable” diseases through an emerging field in cell biology…

Full article